Filing Details
- Accession Number:
- 0001127602-25-010624
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-31 10:39:25
- Reporting Period:
- 2025-03-27
- Filing Date:
- 2025-03-31
- Accepted Time:
- 2025-03-31 10:39:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Labcorp Holdings Inc. | LH | Services-Medical Laboratories (8071) | 992588107 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1793112 | S Mark Schroeder | 531 South Spring Street Burlington NC 27215 | Evp, Pres Diagnostics & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-27 | 4,840 | $0.00 | 9,800 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-03-27 | 2,205 | $231.67 | 7,595 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2025-03-28 | 2,635 | $231.67 | 4,960 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024.
- Stock withholding to satisfy tax withholding obligations.
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
